[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @LegendUSMA Legend Biotech Medical Affairs Legend Biotech Medical Affairs posts on X about events, ash, longterm, stanford university the most. They currently have XXX followers and X posts still getting attention that total XX engagements in the last XX hours. ### Engagements: XX [#](/creator/twitter::1920583888587706368/interactions)  - X Week XXXXX +11,961% - X Month XXXXX +7,459% - X Months XXXXX -XX% ### Mentions: X [#](/creator/twitter::1920583888587706368/posts_active)  - X Months XX -XX% ### Followers: XXX [#](/creator/twitter::1920583888587706368/followers)  - X Week XXX +5.60% - X Month XXX +19% - X Months XXX +126% ### CreatorRank: undefined [#](/creator/twitter::1920583888587706368/influencer_rank)  ### Social Influence **Social topic influence** [events](/topic/events) 28.57%, [ash](/topic/ash) 14.29%, [longterm](/topic/longterm) 14.29%, [stanford university](/topic/stanford-university) 14.29%, [thank you](/topic/thank-you) XXXXX% **Top accounts mentioned or mentioned by** [@endmyeloma](/creator/undefined) [@bhemato](/creator/undefined) [@surbhisidanamd](/creator/undefined) ### Top Social Posts Top posts by engagements in the last XX hours "At the 2025 ASH Annual Meeting our focus remains clear: driving innovation that puts patients at the center. Excited to collaborate and share progress with the hematology community For more link here: #mmsm #lymsm" [X Link](https://x.com/LegendUSMA/status/1996600574091886783) 2025-12-04T15:20Z XXX followers, XXX engagements "Join Dr. Luciano Costa (@End_myeloma) for an oral presentation at #ASH25 to learn about the long-term progression-free survival benefit with a BCMA-directed #CART therapy in standard-risk relapsed / refractory multiple myeloma. For more link here: #mmsm" [X Link](https://x.com/LegendUSMA/status/1997301139071771079) 2025-12-06T13:44Z XXX followers, 1015 engagements "Dr. Binod Dhakal (@bhemato) presents at #ASH25 on effectiveness of bridging therapy corresponds to improved outcomes in the Phase X CARTITUDE-4 study of patients with relapsed lenalidomide-refractory multiple myeloma. For more link here: #mmsm #CART" [X Link](https://x.com/LegendUSMA/status/1997370555536683319) 2025-12-06T18:20Z XXX followers, XXX engagements "Robert Bowden (Johnson & Johnson) presents at #ASH25 on improved manufacturing outcomes with BCMA-directed #CART therapy in earlier lines of therapy. For more link here: #mmsm" [X Link](https://x.com/LegendUSMA/status/1997380930286072158) 2025-12-06T19:01Z XXX followers, XXX engagements "At #ASH25 Dr. Doris Hansen presents real-world incidence and management of non-ICANS neurological events following a BCMA-directed #CART cell therapy in multiple myeloma. Link: #mmsm" [X Link](https://x.com/LegendUSMA/status/1997696306278797566) 2025-12-07T15:54Z XXX followers, XXX engagements "Dr. Surbhi Sidana (@SurbhiSidanaMD) of Stanford University presents a quality-adjusted survival analysis of neurological events with a BCMA-directed #CART therapy vs standard of care in multiple myeloma patients in the CARTITUDE-4 trial. Link: #mmsm" [X Link](https://x.com/LegendUSMA/status/1998021147917791403) 2025-12-08T13:25Z XXX followers, XXX engagements "A heartfelt thank you to all who joined us at #ASH25 attended sessions and visited our posters. Together were pushing boundaries in #CART therapy and accelerating better outcomes for patients with #mmsm and #lymsm" [X Link](https://x.com/LegendUSMA/status/1998498870704361546) 2025-12-09T21:03Z XXX followers, XX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@LegendUSMA Legend Biotech Medical AffairsLegend Biotech Medical Affairs posts on X about events, ash, longterm, stanford university the most. They currently have XXX followers and X posts still getting attention that total XX engagements in the last XX hours.
Social topic influence events 28.57%, ash 14.29%, longterm 14.29%, stanford university 14.29%, thank you XXXXX%
Top accounts mentioned or mentioned by @endmyeloma @bhemato @surbhisidanamd
Top posts by engagements in the last XX hours
"At the 2025 ASH Annual Meeting our focus remains clear: driving innovation that puts patients at the center. Excited to collaborate and share progress with the hematology community For more link here: #mmsm #lymsm"
X Link 2025-12-04T15:20Z XXX followers, XXX engagements
"Join Dr. Luciano Costa (@End_myeloma) for an oral presentation at #ASH25 to learn about the long-term progression-free survival benefit with a BCMA-directed #CART therapy in standard-risk relapsed / refractory multiple myeloma. For more link here: #mmsm"
X Link 2025-12-06T13:44Z XXX followers, 1015 engagements
"Dr. Binod Dhakal (@bhemato) presents at #ASH25 on effectiveness of bridging therapy corresponds to improved outcomes in the Phase X CARTITUDE-4 study of patients with relapsed lenalidomide-refractory multiple myeloma. For more link here: #mmsm #CART"
X Link 2025-12-06T18:20Z XXX followers, XXX engagements
"Robert Bowden (Johnson & Johnson) presents at #ASH25 on improved manufacturing outcomes with BCMA-directed #CART therapy in earlier lines of therapy. For more link here: #mmsm"
X Link 2025-12-06T19:01Z XXX followers, XXX engagements
"At #ASH25 Dr. Doris Hansen presents real-world incidence and management of non-ICANS neurological events following a BCMA-directed #CART cell therapy in multiple myeloma. Link: #mmsm"
X Link 2025-12-07T15:54Z XXX followers, XXX engagements
"Dr. Surbhi Sidana (@SurbhiSidanaMD) of Stanford University presents a quality-adjusted survival analysis of neurological events with a BCMA-directed #CART therapy vs standard of care in multiple myeloma patients in the CARTITUDE-4 trial. Link: #mmsm"
X Link 2025-12-08T13:25Z XXX followers, XXX engagements
"A heartfelt thank you to all who joined us at #ASH25 attended sessions and visited our posters. Together were pushing boundaries in #CART therapy and accelerating better outcomes for patients with #mmsm and #lymsm"
X Link 2025-12-09T21:03Z XXX followers, XX engagements
/creator/twitter::LegendUSMA